Global Still’s Disease Treatment Market Insights, Forecast to 2028

Report ID: 1754068 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Still’s Disease Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Corticosteroids
        1.2.3 Tocilizumab
        1.2.4 Canakinumab
        1.2.5 Anakinra
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Still’s Disease Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Retail Pharmacies
        1.3.3 Hospital Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Still’s Disease Treatment Market Perspective (2017-2028)
    2.2 Still’s Disease Treatment Growth Trends by Region
        2.2.1 Still’s Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Still’s Disease Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Still’s Disease Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Still’s Disease Treatment Market Dynamics
        2.3.1 Still’s Disease Treatment Industry Trends
        2.3.2 Still’s Disease Treatment Market Drivers
        2.3.3 Still’s Disease Treatment Market Challenges
        2.3.4 Still’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Still’s Disease Treatment Players by Revenue
        3.1.1 Global Top Still’s Disease Treatment Players by Revenue (2017-2022)
        3.1.2 Global Still’s Disease Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Still’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Still’s Disease Treatment Revenue
    3.4 Global Still’s Disease Treatment Market Concentration Ratio
        3.4.1 Global Still’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Still’s Disease Treatment Revenue in 2021
    3.5 Still’s Disease Treatment Key Players Head office and Area Served
    3.6 Key Players Still’s Disease Treatment Product Solution and Service
    3.7 Date of Enter into Still’s Disease Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Still’s Disease Treatment Breakdown Data by Type
    4.1 Global Still’s Disease Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Still’s Disease Treatment Forecasted Market Size by Type (2023-2028)
5 Still’s Disease Treatment Breakdown Data by Application
    5.1 Global Still’s Disease Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Still’s Disease Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Still’s Disease Treatment Market Size (2017-2028)
    6.2 North America Still’s Disease Treatment Market Size by Type
        6.2.1 North America Still’s Disease Treatment Market Size by Type (2017-2022)
        6.2.2 North America Still’s Disease Treatment Market Size by Type (2023-2028)
        6.2.3 North America Still’s Disease Treatment Market Share by Type (2017-2028)
    6.3 North America Still’s Disease Treatment Market Size by Application
        6.3.1 North America Still’s Disease Treatment Market Size by Application (2017-2022)
        6.3.2 North America Still’s Disease Treatment Market Size by Application (2023-2028)
        6.3.3 North America Still’s Disease Treatment Market Share by Application (2017-2028)
    6.4 North America Still’s Disease Treatment Market Size by Country
        6.4.1 North America Still’s Disease Treatment Market Size by Country (2017-2022)
        6.4.2 North America Still’s Disease Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Still’s Disease Treatment Market Size (2017-2028)
    7.2 Europe Still’s Disease Treatment Market Size by Type
        7.2.1 Europe Still’s Disease Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Still’s Disease Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Still’s Disease Treatment Market Share by Type (2017-2028)
    7.3 Europe Still’s Disease Treatment Market Size by Application
        7.3.1 Europe Still’s Disease Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Still’s Disease Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Still’s Disease Treatment Market Share by Application (2017-2028)
    7.4 Europe Still’s Disease Treatment Market Size by Country
        7.4.1 Europe Still’s Disease Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Still’s Disease Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Still’s Disease Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Still’s Disease Treatment Market Size by Type
        8.2.1 Asia-Pacific Still’s Disease Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Still’s Disease Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Still’s Disease Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Still’s Disease Treatment Market Size by Application
        8.3.1 Asia-Pacific Still’s Disease Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Still’s Disease Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Still’s Disease Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Still’s Disease Treatment Market Size by Region
        8.4.1 Asia-Pacific Still’s Disease Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Still’s Disease Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Still’s Disease Treatment Market Size (2017-2028)
    9.2 Latin America Still’s Disease Treatment Market Size by Type
        9.2.1 Latin America Still’s Disease Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Still’s Disease Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Still’s Disease Treatment Market Share by Type (2017-2028)
    9.3 Latin America Still’s Disease Treatment Market Size by Application
        9.3.1 Latin America Still’s Disease Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Still’s Disease Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Still’s Disease Treatment Market Share by Application (2017-2028)
    9.4 Latin America Still’s Disease Treatment Market Size by Country
        9.4.1 Latin America Still’s Disease Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Still’s Disease Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Still’s Disease Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Still’s Disease Treatment Market Size by Type
        10.2.1 Middle East & Africa Still’s Disease Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Still’s Disease Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Still’s Disease Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Still’s Disease Treatment Market Size by Application
        10.3.1 Middle East & Africa Still’s Disease Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Still’s Disease Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Still’s Disease Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Still’s Disease Treatment Market Size by Country
        10.4.1 Middle East & Africa Still’s Disease Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Still’s Disease Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AB2 Bio Ltd
        11.1.1 AB2 Bio Ltd Company Details
        11.1.2 AB2 Bio Ltd Business Overview
        11.1.3 AB2 Bio Ltd Still’s Disease Treatment Introduction
        11.1.4 AB2 Bio Ltd Revenue in Still’s Disease Treatment Business (2017-2022)
        11.1.5 AB2 Bio Ltd Recent Developments
    11.2 Novartis AG
        11.2.1 Novartis AG Company Details
        11.2.2 Novartis AG Business Overview
        11.2.3 Novartis AG Still’s Disease Treatment Introduction
        11.2.4 Novartis AG Revenue in Still’s Disease Treatment Business (2017-2022)
        11.2.5 Novartis AG Recent Developments
    11.3 F. Hoffmann-La Roche Ltd
        11.3.1 F. Hoffmann-La Roche Ltd Company Details
        11.3.2 F. Hoffmann-La Roche Ltd Business Overview
        11.3.3 F. Hoffmann-La Roche Ltd Still’s Disease Treatment Introduction
        11.3.4 F. Hoffmann-La Roche Ltd Revenue in Still’s Disease Treatment Business (2017-2022)
        11.3.5 F. Hoffmann-La Roche Ltd Recent Developments
    11.4 Swedish Orphan Biovitrum AB
        11.4.1 Swedish Orphan Biovitrum AB Company Details
        11.4.2 Swedish Orphan Biovitrum AB Business Overview
        11.4.3 Swedish Orphan Biovitrum AB Still’s Disease Treatment Introduction
        11.4.4 Swedish Orphan Biovitrum AB Revenue in Still’s Disease Treatment Business (2017-2022)
        11.4.5 Swedish Orphan Biovitrum AB Recent Developments
    11.5 Jubilant
        11.5.1 Jubilant Company Details
        11.5.2 Jubilant Business Overview
        11.5.3 Jubilant Still’s Disease Treatment Introduction
        11.5.4 Jubilant Revenue in Still’s Disease Treatment Business (2017-2022)
        11.5.5 Jubilant Recent Developments
    11.6 Hikma Pharmaceuticals PLC
        11.6.1 Hikma Pharmaceuticals PLC Company Details
        11.6.2 Hikma Pharmaceuticals PLC Business Overview
        11.6.3 Hikma Pharmaceuticals PLC Still’s Disease Treatment Introduction
        11.6.4 Hikma Pharmaceuticals PLC Revenue in Still’s Disease Treatment Business (2017-2022)
        11.6.5 Hikma Pharmaceuticals PLC Recent Developments
    11.7 Teva Pharmaceutical Industries Ltd
        11.7.1 Teva Pharmaceutical Industries Ltd Company Details
        11.7.2 Teva Pharmaceutical Industries Ltd Business Overview
        11.7.3 Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Introduction
        11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2017-2022)
        11.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
    11.8 Viatris
        11.8.1 Viatris Company Details
        11.8.2 Viatris Business Overview
        11.8.3 Viatris Still’s Disease Treatment Introduction
        11.8.4 Viatris Revenue in Still’s Disease Treatment Business (2017-2022)
        11.8.5 Viatris Recent Developments
    11.9 Horizon Therapeutics plc
        11.9.1 Horizon Therapeutics plc Company Details
        11.9.2 Horizon Therapeutics plc Business Overview
        11.9.3 Horizon Therapeutics plc Still’s Disease Treatment Introduction
        11.9.4 Horizon Therapeutics plc Revenue in Still’s Disease Treatment Business (2017-2022)
        11.9.5 Horizon Therapeutics plc Recent Developments
    11.10 Sun Pharmaceutical Industries Ltd
        11.10.1 Sun Pharmaceutical Industries Ltd Company Details
        11.10.2 Sun Pharmaceutical Industries Ltd Business Overview
        11.10.3 Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Introduction
        11.10.4 Sun Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2017-2022)
        11.10.5 Sun Pharmaceutical Industries Ltd Recent Developments
    11.11 Zydus Cadila
        11.11.1 Zydus Cadila Company Details
        11.11.2 Zydus Cadila Business Overview
        11.11.3 Zydus Cadila Still’s Disease Treatment Introduction
        11.11.4 Zydus Cadila Revenue in Still’s Disease Treatment Business (2017-2022)
        11.11.5 Zydus Cadila Recent Developments
    11.12 Amneal Pharmaceuticals LLC
        11.12.1 Amneal Pharmaceuticals LLC Company Details
        11.12.2 Amneal Pharmaceuticals LLC Business Overview
        11.12.3 Amneal Pharmaceuticals LLC Still’s Disease Treatment Introduction
        11.12.4 Amneal Pharmaceuticals LLC Revenue in Still’s Disease Treatment Business (2017-2022)
        11.12.5 Amneal Pharmaceuticals LLC Recent Developments
    11.13 Dr Reddy's Laboratories Ltd
        11.13.1 Dr Reddy's Laboratories Ltd Company Details
        11.13.2 Dr Reddy's Laboratories Ltd Business Overview
        11.13.3 Dr Reddy's Laboratories Ltd Still’s Disease Treatment Introduction
        11.13.4 Dr Reddy's Laboratories Ltd Revenue in Still’s Disease Treatment Business (2017-2022)
        11.13.5 Dr Reddy's Laboratories Ltd Recent Developments
    11.14 Fresenius Kabi AG
        11.14.1 Fresenius Kabi AG Company Details
        11.14.2 Fresenius Kabi AG Business Overview
        11.14.3 Fresenius Kabi AG Still’s Disease Treatment Introduction
        11.14.4 Fresenius Kabi AG Revenue in Still’s Disease Treatment Business (2017-2022)
        11.14.5 Fresenius Kabi AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Still’s Disease Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Corticosteroids
    Table 3. Key Players of Tocilizumab
    Table 4. Key Players of Canakinumab
    Table 5. Key Players of Anakinra
    Table 6. Key Players of Others
    Table 7. Global Still’s Disease Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Still’s Disease Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Still’s Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Still’s Disease Treatment Market Share by Region (2017-2022)
    Table 11. Global Still’s Disease Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Still’s Disease Treatment Market Share by Region (2023-2028)
    Table 13. Still’s Disease Treatment Market Trends
    Table 14. Still’s Disease Treatment Market Drivers
    Table 15. Still’s Disease Treatment Market Challenges
    Table 16. Still’s Disease Treatment Market Restraints
    Table 17. Global Still’s Disease Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Still’s Disease Treatment Revenue Share by Players (2017-2022)
    Table 19. Global Top Still’s Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still’s Disease Treatment as of 2021)
    Table 20. Ranking of Global Top Still’s Disease Treatment Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Still’s Disease Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Still’s Disease Treatment Product Solution and Service
    Table 24. Date of Enter into Still’s Disease Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Still’s Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Still’s Disease Treatment Revenue Market Share by Type (2017-2022)
    Table 28. Global Still’s Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Still’s Disease Treatment Revenue Market Share by Type (2023-2028)
    Table 30. Global Still’s Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Still’s Disease Treatment Revenue Share by Application (2017-2022)
    Table 32. Global Still’s Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Still’s Disease Treatment Revenue Share by Application (2023-2028)
    Table 34. North America Still’s Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Still’s Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Still’s Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Still’s Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Still’s Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Still’s Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Still’s Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Still’s Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Still’s Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Still’s Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Still’s Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Still’s Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Still’s Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Still’s Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Still’s Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Still’s Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Still’s Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Still’s Disease Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Still’s Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Still’s Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Still’s Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Still’s Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Still’s Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Still’s Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Still’s Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Still’s Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Still’s Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Still’s Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Still’s Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Still’s Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 64. AB2 Bio Ltd Company Details
    Table 65. AB2 Bio Ltd Business Overview
    Table 66. AB2 Bio Ltd Still’s Disease Treatment Product
    Table 67. AB2 Bio Ltd Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 68. AB2 Bio Ltd Recent Developments
    Table 69. Novartis AG Company Details
    Table 70. Novartis AG Business Overview
    Table 71. Novartis AG Still’s Disease Treatment Product
    Table 72. Novartis AG Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 73. Novartis AG Recent Developments
    Table 74. F. Hoffmann-La Roche Ltd Company Details
    Table 75. F. Hoffmann-La Roche Ltd Business Overview
    Table 76. F. Hoffmann-La Roche Ltd Still’s Disease Treatment Product
    Table 77. F. Hoffmann-La Roche Ltd Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 78. F. Hoffmann-La Roche Ltd Recent Developments
    Table 79. Swedish Orphan Biovitrum AB Company Details
    Table 80. Swedish Orphan Biovitrum AB Business Overview
    Table 81. Swedish Orphan Biovitrum AB Still’s Disease Treatment Product
    Table 82. Swedish Orphan Biovitrum AB Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 83. Swedish Orphan Biovitrum AB Recent Developments
    Table 84. Jubilant Company Details
    Table 85. Jubilant Business Overview
    Table 86. Jubilant Still’s Disease Treatment Product
    Table 87. Jubilant Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 88. Jubilant Recent Developments
    Table 89. Hikma Pharmaceuticals PLC Company Details
    Table 90. Hikma Pharmaceuticals PLC Business Overview
    Table 91. Hikma Pharmaceuticals PLC Still’s Disease Treatment Product
    Table 92. Hikma Pharmaceuticals PLC Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 93. Hikma Pharmaceuticals PLC Recent Developments
    Table 94. Teva Pharmaceutical Industries Ltd Company Details
    Table 95. Teva Pharmaceutical Industries Ltd Business Overview
    Table 96. Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Product
    Table 97. Teva Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 98. Teva Pharmaceutical Industries Ltd Recent Developments
    Table 99. Viatris Company Details
    Table 100. Viatris Business Overview
    Table 101. Viatris Still’s Disease Treatment Product
    Table 102. Viatris Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 103. Viatris Recent Developments
    Table 104. Horizon Therapeutics plc Company Details
    Table 105. Horizon Therapeutics plc Business Overview
    Table 106. Horizon Therapeutics plc Still’s Disease Treatment Product
    Table 107. Horizon Therapeutics plc Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 108. Horizon Therapeutics plc Recent Developments
    Table 109. Sun Pharmaceutical Industries Ltd Company Details
    Table 110. Sun Pharmaceutical Industries Ltd Business Overview
    Table 111. Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Product
    Table 112. Sun Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 113. Sun Pharmaceutical Industries Ltd Recent Developments
    Table 114. Zydus Cadila Company Details
    Table 115. Zydus Cadila Business Overview
    Table 116. Zydus Cadila Still’s Disease Treatment Product
    Table 117. Zydus Cadila Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 118. Zydus Cadila Recent Developments
    Table 119. Amneal Pharmaceuticals LLC Company Details
    Table 120. Amneal Pharmaceuticals LLC Business Overview
    Table 121. Amneal Pharmaceuticals LLC Still’s Disease Treatment Product
    Table 122. Amneal Pharmaceuticals LLC Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 123. Amneal Pharmaceuticals LLC Recent Developments
    Table 124. Dr Reddy's Laboratories Ltd Company Details
    Table 125. Dr Reddy's Laboratories Ltd Business Overview
    Table 126. Dr Reddy's Laboratories Ltd Still’s Disease Treatment Product
    Table 127. Dr Reddy's Laboratories Ltd Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 128. Dr Reddy's Laboratories Ltd Recent Developments
    Table 129. Fresenius Kabi AG Company Details
    Table 130. Fresenius Kabi AG Business Overview
    Table 131. Fresenius Kabi AG Still’s Disease Treatment Product
    Table 132. Fresenius Kabi AG Revenue in Still’s Disease Treatment Business (2017-2022) & (US$ Million)
    Table 133. Fresenius Kabi AG Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Still’s Disease Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Corticosteroids Features
    Figure 3. Tocilizumab Features
    Figure 4. Canakinumab Features
    Figure 5. Anakinra Features
    Figure 6. Others Features
    Figure 7. Global Still’s Disease Treatment Market Share by Application: 2021 VS 2028
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Hospital Pharmacies Case Studies
    Figure 10. Online Pharmacies Case Studies
    Figure 11. Still’s Disease Treatment Report Years Considered
    Figure 12. Global Still’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Still’s Disease Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Still’s Disease Treatment Market Share by Region: 2021 VS 2028
    Figure 15. Global Still’s Disease Treatment Market Share by Players in 2021
    Figure 16. Global Top Still’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still’s Disease Treatment as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Still’s Disease Treatment Revenue in 2021
    Figure 18. North America Still’s Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Still’s Disease Treatment Market Size Market Share by Type (2017-2028)
    Figure 20. North America Still’s Disease Treatment Market Size Market Share by Application (2017-2028)
    Figure 21. North America Still’s Disease Treatment Market Size Share by Country (2017-2028)
    Figure 22. United States Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Still’s Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Still’s Disease Treatment Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Still’s Disease Treatment Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Still’s Disease Treatment Market Size Share by Country (2017-2028)
    Figure 28. Germany Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Still’s Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Still’s Disease Treatment Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Still’s Disease Treatment Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Still’s Disease Treatment Market Size Share by Region (2017-2028)
    Figure 38. China Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Still’s Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Still’s Disease Treatment Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Still’s Disease Treatment Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Still’s Disease Treatment Market Size Share by Country (2017-2028)
    Figure 48. Mexico Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Still’s Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Still’s Disease Treatment Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Still’s Disease Treatment Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Still’s Disease Treatment Market Size Share by Country (2017-2028)
    Figure 54. Turkey Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Still’s Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. AB2 Bio Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 58. Novartis AG Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 59. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 60. Swedish Orphan Biovitrum AB Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 61. Jubilant Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 62. Hikma Pharmaceuticals PLC Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 63. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 64. Viatris Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 65. Horizon Therapeutics plc Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 66. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 67. Zydus Cadila Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 68. Amneal Pharmaceuticals LLC Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 69. Dr Reddy's Laboratories Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 70. Fresenius Kabi AG Revenue Growth Rate in Still’s Disease Treatment Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AB2 Bio Ltd
Novartis AG
F. Hoffmann-La Roche Ltd
Swedish Orphan Biovitrum AB
Jubilant
Hikma Pharmaceuticals PLC
Teva Pharmaceutical Industries Ltd
Viatris
Horizon Therapeutics plc
Sun Pharmaceutical Industries Ltd
Zydus Cadila
Amneal Pharmaceuticals LLC
Dr Reddy's Laboratories Ltd
Fresenius Kabi AG
Frequently Asked Questions
Still’s Disease Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Still’s Disease Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Still’s Disease Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Batch Peelers

Batch Peelers market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More